Victor Guallar Tasies
-
- Position: ELECTRONIC AND ATOMIC PROTEIN MODELLING GROUP MANAGER
- Life Sciences - Electronic and Atomic Protein Modelling
- email: victor [dot] guallar [at] bsc [dot] es
- Tel: +34 934137727
Primary tabs
Es esencial diseñar antivirales capaces de inhibir, a la vez, diversos coronaviruses, introduciendo así una serie de moléculas que puedan actuar como primera línea de choque en mutaciones de SARS-CoV-2 y en las pandemia venideras. Para ello, es imprescindible localizar dianas con alta similitud, bien caracterizadas estructuralmente, y realizar un...
The EXSCALATE4CoV (E4C) project aims to exploit the most powerful computing resources currently based in Europe to empowersmart in-silico drug design. Advanced Computer-Aided Drug Design (CADD) in combination with the high throughput biochemicaland phenotypic screening will allow the rapid evaluation of the simulations results and the reduction of time for the discovery ofnew...
The increasing shift to eco-friendly production impacts the industry of consumer products. The EU-funded FuturEnzyme project will develop advanced innovative solutions to discover, design, optimise and formulate low-cost enzymes for economically viable products in the textile, detergent and cosmetics sectors. A textile containing Elasthane, a liquid detergent, and a...
In this project, we present PluriZymes, enzymes containing multiple (engineered) catalytic actives sites in a single scaffold, as one of the next breakthroughs in enzymatic catalysis. We show clear preliminary evidence of the potential role of PluriZymes in optimizing complex biochemical processes, such as cellulose degradation, or to group cascade reactions into one single...